Expression of MAGE, GAGE and BAGE genes in human liver diseases: utility as molecular markers for hepatocellular carcinoma

This publication has 33 references indexed in Scilit:

• Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGES‐3
  International Journal of Cancer, 1995
• The expression of tumor-rejection antigen “MAGE” genes in human gastric carcinoma
  Gastroenterology, 1995
• Terminology of nodular hepatocellular lesions
  Hepatology, 1995
• A peptide encoded by human gene MAGE‐3 and presented by HLA‐A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE‐3
  European Journal of Immunology, 1994
• Imaging Diagnosis of Small Hepatocellular Carcinoma
  Hepatology, 1994
• HLA-A and DPB1 loci confer susceptibility to Grave's disease
  Human Immunology, 1992
• A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma
  Science, 1991
• Transcatheter arterial injection of autologous lymphokine-activated killer (LAK) cells into patients with liver cancers
  Journal of Clinical Immunology, 1990
• Prognostic factors after hepatectomy for hepatocellular carcinomas. A univariate and multivariate analysis
  Cancer, 1990
• Des-γ-Carboxy (Abnormal) Prothrombin as a Serum Marker of Primary Hepatocellular Carcinoma
  New England Journal of Medicine, 1984